0001870913-23-000007.txt : 20230919
0001870913-23-000007.hdr.sgml : 20230919
20230919171455
ACCESSION NUMBER: 0001870913-23-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230915
FILED AS OF DATE: 20230919
DATE AS OF CHANGE: 20230919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shanmugam Muthusamy
CENTRAL INDEX KEY: 0001870913
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 231264639
MAIL ADDRESS:
STREET 1: C/O ANI PHARMACEUTICALS, INC.
STREET 2: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001023024
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 582301143
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
BUSINESS PHONE: 2186343500
MAIL ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
FORMER COMPANY:
FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19991228
FORMER COMPANY:
FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991027
4
1
wk-form4_1695158086.xml
FORM 4
X0508
4
2023-09-15
0
0001023024
ANI PHARMACEUTICALS INC
ANIP
0001870913
Shanmugam Muthusamy
C/O ANI PHARMACEUTICALS, INC.
210 MAIN STREET WEST
BAUDETTE
MN
56623
1
1
0
0
HEAD OF R&D, COO-NOVITIUM OPS
1
Common Stock
47407
D
Common Stock
2023-09-15
4
S
0
16242
62.81
D
1116378
I
Held by Esjay LLC
Common Stock
2023-09-18
4
S
0
8425
61.64
D
1107953
I
Held by Esjay LLC
Common Stock
2023-09-19
4
S
0
25333
61.23
D
1082620
I
Held by Esjay LLC
Common Stock
5000
I
Held by SS Pharma LLC
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.01 to $63.82, inclusive.
The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $61.23 to $62.94, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.63 to $61.69, inclusive.
The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.
/s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook
2023-09-19